NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 1 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48 | -60.7% | 44,286 | -5.7% | 0.00% | – |
| Q2 2023 | $122 | -36.5% | 46,963 | 0.0% | 0.00% | – |
| Q1 2023 | $192 | -5.0% | 46,963 | +16.9% | 0.00% | – |
| Q4 2022 | $202 | -100.0% | 40,187 | +18.4% | 0.00% | – |
| Q3 2022 | $445,000 | +69.8% | 33,945 | +66.1% | 0.00% | – |
| Q2 2022 | $262,000 | -9.7% | 20,440 | +7.5% | 0.00% | – |
| Q1 2022 | $290,000 | -10.2% | 19,015 | +4.4% | 0.00% | – |
| Q4 2021 | $323,000 | -96.0% | 18,220 | -95.3% | 0.00% | -100.0% |
| Q3 2021 | $8,087,000 | -5.5% | 384,716 | -11.3% | 0.00% | 0.0% |
| Q2 2021 | $8,556,000 | -22.4% | 433,858 | +14.3% | 0.00% | 0.0% |
| Q1 2021 | $11,031,000 | – | 379,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $232,513,000 | 49.48% |
| Ponoi II Management, LLC | 1,298,908 | $16,652,000 | 45.25% |
| Ponoi Management, LLC | 1,298,908 | $16,652,000 | 26.29% |
| Euclidean Capital LLC | 746,674 | $9,572,000 | 8.14% |
| StepStone Group LP | 1,573,357 | $20,170,000 | 2.16% |
| First Light Asset Management, LLC | 1,135,884 | $14,562,000 | 1.69% |
| Lexington Partners L.P. | 110,428 | $1,416,000 | 0.73% |
| Rubric Capital Management LP | 797,588 | $10,225,000 | 0.54% |
| Boxer Capital, LLC | 500,000 | $6,410,000 | 0.41% |
| DAFNA Capital Management LLC | 107,653 | $1,380,000 | 0.38% |